Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.225 GBX | -9.15% | -15.13% | -24.12% |
08:56pm | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
15/04 | Fusion Antibodies inks commercial contract for OptiPhage library | AN |
Sales 2024 * | 1.15M 1.44M 120M | Sales 2025 * | - | Capitalization | 3.08M 3.84M 321M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.25M -104M | Net income 2025 * | - | EV / Sales 2024 * | 2.67 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.27
x | P/E ratio 2025 * |
-
| Employees | 48 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.63% |
1 day | -9.15% | ||
1 week | -15.13% | ||
Current month | -14.00% | ||
1 month | -16.23% | ||
3 months | -25.86% | ||
6 months | -38.57% | ||
Current year | -24.12% |
Managers | Title | Age | Since |
---|---|---|---|
Adrian Kinkaid
CEO | Chief Executive Officer | 57 | 15/22/15 |
Stephen Smyth
DFI | Director of Finance/CFO | 49 | 24/23/24 |
Simon Douglas
CHM | Chairman | 65 | 01/06/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Colin Walsh
BRD | Director/Board Member | 68 | 01/07/01 |
Simon Douglas
CHM | Chairman | 65 | 01/06/01 |
Richard Buick
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/01 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 3.225 | -9.15% | 2 262 192 |
29/24/29 | 3.55 | -2.74% | 340,618 |
26/24/26 | 3.65 | -2.67% | 167,778 |
25/24/25 | 3.75 | 0.00% | 220,253 |
24/24/24 | 3.75 | -1.32% | 187,413 |
Delayed Quote London S.E., April 30, 2024 at 09:05 pm IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.12% | 4.25M | |
+0.47% | 42.86B | |
+11.86% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.54% | 25.15B | |
-24.23% | 18.63B | |
+27.67% | 12.37B | |
-3.06% | 11.92B | |
+7.08% | 11.21B |
- Stock Market
- Equities
- FAB Stock